GS3-007a Dry Suspension

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS3-007a Dry Suspension, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults [Phase 1]